Display Selection of a Hybrid Foldamer-Peptide Macrocycle

03 February 2022, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

A helical aromatic foldamer was identified that undergoes tRNA acylation by a flexizyme and ribosomal peptide initiation with yields sufficiently high to perform an mRNA display selection of macrocyclic foldamer-peptide hybrids. A hybrid macrocyle binder to the C-lobe of the E6AP HECT domain was selected that showed highly converged peptide residues. A crystal structure and molecular dynamics simulations revealed that both the peptide and foldamer are helical in an intriguing reciprocal stapling fashion. The strong residue convergence could be rationalized based on their involvement in specific interactions. The foldamer stabilizes the peptide helix through stapling and through contacts with key residues. It appears to also contribute to protein binding by direct protein interactions. The results altogether highlight possible benefits in inserting an aromatic foldamer into a peptide macrocycle for the purpose of protein recognition.

Keywords

Foldamer • Macrocycle • Peptide • Display selection • Protein recognition

Supplementary materials

Title
Description
Actions
Title
Display Selection of a Hybrid Foldamer-Peptide Macrocycle
Description
Supplementary Information: including 1) supporting figures (S1-S27); 2) materials and general methods for biochemistry and structural biology; 3) chemical synthesis with detailed experimental protocols of solid phase synthesis of compounds 1-12 and 4) characterization of foldamer-peptide hybrid sequences (linear and macrocycles).
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.